In particular, the expression of KCNK1 was decreased more in cancers of the overall CNS—such as astrocytomas (AC), GBMs, ODs, medulloblastomas, and melanomas—than in the normal tissue. This evidence concerns the gene KCNK1 and astrocytoma (excluding glioblastoma).